Serial Number
78229836
Owner
MINDSET BIOPHARMACEUTICALS (USA), INC.Attorney
J. Scott EvansFiling Date
Mar 25, 2003
EPTEST Trademark
Serial Number: 78229836
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
1450 BROADWAY, 41ST FLOOR
NEW YORK, NY 10018
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
March 25, 2003
Registration Date
Not Registered
Goods & Services
Pharmaceutical preparations; antibody preparations; chemical preparations for use in performing polymerase chain reactions (PCR); monoclonal antibodies; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to antigens; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to vaccines; diagnostic preparations and reagents for sale in kit form; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; DNA; RNA; peptides; polypeptides; proteins; recombinant antibodies; vaccines; including all of the above aforesaid goods for the treatment of amyloidosis, Alzheimer's Disease, Down Syndrome and Mild Cognitive Impairment (MCI); Pharmaceutical preparations; antibody preparations; chemical preparations for use in performing polymerase chain reactions (PCR); monoclonal antibodies; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to antigens; chemical preparations for determination of the reaction of an individual's human leucocyte antigen (HLA) haplotype to vaccines; diagnostic preparations and reagents for sale in kit form; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; DNA; RNA; peptides; polypeptides; proteins; recombinant antibodies; vaccines; including all of the above aforesaid goods for the treatment of amyloidosis, Alzheimer's Disease, Down Syndrome and Mild Cognitive Impairment (MCI)
Diagnostic test kits; diagnostic test kits for use in polymerase chain reactions (PCR) ; diagnostic test kits and apparatus for determination of an individual's HLA haplotype reaction with vaccines; all the aforesaid for determination of an individual's HLA haplotype reaction with vaccines against Alzheimer's Disease, MCI, amyloidosis and Down Syndrome.; Diagnostic test kits; diagnostic test kits for use in polymerase chain reactions (PCR) ; diagnostic test kits and apparatus for determination of an individual's HLA haplotype reaction with vaccines; all the aforesaid for determination of an individual's HLA haplotype reaction with vaccines against Alzheimer's Disease, MCI, amyloidosis and Down Syndrome.
Scientific, medical and industrial research; vaccine screening; biochemical analysis, biochemical research; diagnosis of predisposition to Alzheimer's Disease, Mild Cognitive Impairment (MCI); amyloidosis and Down Syndrome; disease management; drug design; healthcare; prophylaxis and treatment of medical disorders; prophylaxis, vaccination, vaccine screening, and treatment of Alzheimer's Disease, Down Syndrome, Mild Cognitive Impairment (MCI) and amyloidosis.; Scientific, medical and industrial research; vaccine screening; biochemical analysis, biochemical research; diagnosis of predisposition to Alzheimer's Disease, Mild Cognitive Impairment (MCI); amyloidosis and Down Syndrome; disease management; drug design; healthcare; prophylaxis and treatment of medical disorders; prophylaxis, vaccination, vaccine screening, and treatment of Alzheimer's Disease, Down Syndrome, Mild Cognitive Impairment (MCI) and amyloidosis.